These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1666494)

  • 41. Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
    Reed JM; Gardner SG; Mishra NN; Bayer AS; Somerville GA
    J Antimicrob Chemother; 2019 Aug; 74(8):2274-2283. PubMed ID: 31074482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of daptomycin against 297 staphylococcal isolates.
    Digranes A; Benonisen E
    Chemotherapy; 1990; 36(2):136-40. PubMed ID: 2155761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus
    Barros EM; Martin MJ; Selleck EM; Lebreton F; Sampaio JLM; Gilmore MS
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
    Akins RL; Rybak MJ
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1925-9. PubMed ID: 10858356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membrane potential and gentamicin uptake in Staphylococcus aureus.
    Mates SM; Eisenberg ES; Mandel LJ; Patel L; Kaback HR; Miller MH
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6693-7. PubMed ID: 6959147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
    Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
    LaPlante KL; Rybak MJ
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of LY146032 (daptomycin), a new peptolide.
    Ehlert F; Neu HC
    Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence.
    Stefani S; Campanile F; Santagati M; Mezzatesta ML; Cafiso V; Pacini G
    Int J Antimicrob Agents; 2015 Sep; 46(3):278-89. PubMed ID: 26143590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS; Becker HK; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR; Havill NL; Koeth LM; Boyce JM
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
    DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
    Velazquez A; DeRyke CA; Goering R; Hoover V; Wallace MR
    Clin Microbiol Infect; 2013 Dec; 19(12):1169-72. PubMed ID: 23480569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
    Moise PA; North D; Steenbergen JN; Sakoulas G
    Lancet Infect Dis; 2009 Oct; 9(10):617-24. PubMed ID: 19778764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of membrane potential-dependent amino acid transport by daptomycin.
    Allen NE; Alborn WE; Hobbs JN
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2639-42. PubMed ID: 1687346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae.
    Sorlozano A; Gutiérrez J; Roman J; Liebana J; Piedrola G
    Microb Drug Resist; 2009 Jun; 15(2):125-7. PubMed ID: 19432525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural lipopeptide antibiotic tripropeptin C revitalizes and synergistically potentiates the activity of beta-lactams against methicillin-resistant Staphylococcus aureus.
    Hashizume H; Takahashi Y; Harada S; Nomoto A
    J Antibiot (Tokyo); 2015 Jun; 68(6):373-8. PubMed ID: 25586024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.